catalyx space | $5,400,000 | (Nov 4, 2025)
Hullbot | $16,000,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
Carthera
France
- PARIS, IDF
- 27/06/2023
- Series B
- $41,077,875
Carthera® is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices to treat a wide range of severe brain disorders.
Carthera® has developed a proprietary device called SonoCloud®- a groundbreaking medical device that emits ultrasound to temporarily increase the permeability of the blood vessels in the brain.
By using SonoCloud®, the therapeutic efficacy of new and existing therapies can be unlocked and harnessed to improve the treatment of a wide range of brain diseases: oncology indications (glioblastoma, brain metastasis) or neurodegenerative diseases (such as Alzheimer’s Disease, ALS).
The products developed by Carthera® are in clinical or preclinical evaluation (not FDA or CE approved) and are not available for sale.
- Industry Medical Equipment Manufacturing
- Website https://carthera.eu/
- LinkedIn https://www.linkedin.com/company/carthera/
Zeeg | $1,265,935 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
octonomy | $20,000,000 | (Nov 4, 2025)
Helex | $3,500,000 | (Nov 4, 2025)
Indomo | $25,000,000 | (Nov 4, 2025)
AUI™ (Augmented Intelligence) | $20,000,000 | (Nov 4, 2025)
Popai Health | $11,000,000 | (Nov 4, 2025)
Mem0 | $24,000,000 | (Oct 30, 2025)